Suchergebnisse - "Brown, Kimberley"

PubPharm (46)

1

Baby food pouches and Baby-Led Weaning : Associations with energy intake, eating behaviour and infant weight status

enthalten in: Appetite | 2024

von Cox, A. | Taylor, R. | Haszard, J. | +17

2

Adherence to Infant Feeding Guidelines in the First Foods New Zealand Study

enthalten in: Nutrients | 2023

von Brown, K. | Beck, K. | von Hurst, P. | +18

3

Nutritional Implications of Baby-Led Weaning and Baby Food Pouches as Novel Methods of Infant Feeding : Protocol for an Observational Study

enthalten in: JMIR research protocols | 2021

von Taylor, R. | Conlon, C. | Beck, K. | +19

4

Nutritional Implications of Baby-Led Weaning and Baby Food Pouches as Novel Methods of Infant Feeding: Protocol for an Observational Study

in: JMIR Research Protocols | 2021

von Taylor, R. | Conlon, C. | Beck, K. | +19

5

Week 96 subgroup analyses of the phase 3, randomized AMBER and EMERALD trials evaluating the efficacy and safety of the once daily darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) single-tablet regimen in antiretroviral treatment (ART)-naïve and -experienced, virologically-suppressed adults living with HIV-1

enthalten in: HIV research & clinical practice | 2020

von Huhn, G. | Wilkin, A. | Mussini, C. | +8

6

Dietary Choices of New Zealand Women during Pregnancy and Lactation

enthalten in: Nutrients | 2020

von Brown, K. | von Hurst, P. | Rapson, J. | +1

7

Pooled resistance analyses of darunavir once-daily regimens and formulations across 10 clinical studies of treatment-naïve and treatment-experienced patients with human immunodeficiency virus-1 infection

enthalten in: HIV research & clinical practice | 2020

von Lathouwers, E. | Seyedkazemi, S. | Luo, D. | +3

8

Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials

enthalten in: AIDS research and human retroviruses | 2020

von Lathouwers, E. | Wong, E. | Brown, K. | +108

9

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1

enthalten in: Antiviral research | 2019

von Eron, J. | Orkin, C. | Cunningham, D. | +111

10

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1 : subgroup analyses of the phase 3 EMERALD study

enthalten in: AIDS research and therapy | 2019

von Huhn, G. | Eron, J. | Girard, P. | +10

1
2
3
4
5
Nächster »
[5]